Catalyst Pharmaceuticals Partners, Inc.
S&P 600
$31.49
Delayed · cached 15 min
Frequently asked questions
What sector does Catalyst Pharmaceuticals Partners, Inc. belong to?
Catalyst Pharmaceuticals Partners, Inc. operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of CPRX?
As of the latest available quote, CPRX traded at $31.49. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of CPRX?
Catalyst Pharmaceuticals Partners, Inc. has a price-to-earnings (P/E) ratio of about 18.74. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of CPRX?
The market capitalisation of Catalyst Pharmaceuticals Partners, Inc. is approximately $4.02B.
Is Catalyst Pharmaceuticals Partners, Inc. profitable?
For its latest reported financial year, Catalyst Pharmaceuticals Partners, Inc. recorded a net profit margin of about 36.39%.
What is the return on equity (ROE) of CPRX?
Catalyst Pharmaceuticals Partners, Inc. has a return on equity (ROE) of about 21.16%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of CPRX?
Over the past 52 weeks, CPRX has traded between a low of $19.05 and a high of $32.56.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.